Cardiol Therapeutics Inc. 6-K Filing

From the Filing

EDGAR Filing Documents for 0001062993-26-001780 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001062993-26-001780 Filing Date 2026-04-01 Accepted 2026-04-01 07:29:42 Documents 3 Period of Report 2026-04-01 Document Format Files Seq Description Document Type Size 1 FORM 6-K form6k.htm 6-K 5286 2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 25113 3 GRAPHIC exhibit99-1xu001.jpg GRAPHIC 8359 Complete submission text file 0001062993-26-001780.txt 43125 Mailing Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 Business Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 289-910-0850 Cardiol Therapeutics Inc. (Filer) CIK : 0001702123 (see all company filings) EIN. : 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231 Type: 6-K | Act: 34 | File No.: 001-40712 | Film No.: 26824695 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)